Cognitive Function Is Impaired in Patients with Recently Diagnosed Type 2 Diabetes, but Not Type 1 Diabetes
Table 1
Characteristics of the study participants.
Metabolically healthy individuals,
Individuals with recently diagnosed diabetes,
Individuals with a known diabetes duration of five years,
Healthy individuals
Type 1 diabetes
Type 2 diabetes
Type 1 diabetes
Type 2 diabetes
Number ()
42
82
119
45
65
Male (/%)
35 (83)
47 (57)
76 (64)
27 (60)
41 (63)
Age (years)
49 ± 12
35 ± 10
52 ± 9
41 ± 13
59 ± 10
Body mass index (kg/m2)
29.0 ± 6.1
25.3 ± 3.8
32.0 ± 5.7
25.1 ± 3.0
32.1 ± 5.5
Time since diagnosis (months)
—
5.9 ± 3.0
5.8 ± 3.4
71.4 ± 13.7
70.8 ± 12.8
HbA1c (%)
5.3 ± 0.3
6.3 ± 1.1
6.4 ± 0.9
6.9 ± 1.0
6.9 ± 1.1
HbA1c (mmol/mol)
34 ± 3
45 ± 11
46 ± 10
52 ± 11
52 ± 12
Fasting glucose (mg/dl)
91 ± 8
123 ± 38
131 ± 26
142 ± 49
157 ± 46
Fasting C-peptide (ng/ml)
1.9 (1.4; 2.5)
0.9 (0.5; 1.4)
3.1 (2.4; 4.0)
0.2 (0.1; 0.6)
2.8 (2.3; 4.1)
C-peptide secretion capacity (ng/ml)
3.8 (2.7; 4.9)
0.6 (0.2; 1.4)
3.0 (2.1; 4.0)
0.1 (0.0; 0.4)
3.2 (2.1; 4.4)
value (mg kg−1 min−1)
10.3 (8.5; 12.4)
8.3 (6.8; 10.4)
5.4 (4.2; 7.4)
7.5 (6.1; 8.3)
5.3 (3.8; 6.6)
Data are (%), mean ± SD, or median (25th and 75th percentiles). According to the STROBE guidelines, no value is given [20]. STROBE: Strengthening the Reporting of Observational Studies in Epidemiology.
